Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03560206 · ClinicalTrials.gov registry record · NA
Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads
A NA study, sponsored by Misook L. Chung.
- Completed
- Registry status
- NA
- Development phase
- 316
- Enrollment target
NCT03560206: Completed NA study, sponsored by Misook L. Chung.
NCT03560206 is a NA study that has completed, run by Misook L. Chung. The registered enrollment target is 316 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03560206, a NA study, has completed, sponsored by Misook L. Chung.
- COMPLETED
- Registry status
- NA
- Development phase
- 316 participants
- Enrollment target
Study Summary
The Family Sodium Watcher program in this study is designed to improve adherence to a sodium restricted diet in patients with HF using strategies that educate both patients and family caregivers about sodium monitoring and that stress a gradual progressive adaptation to low sodium food for both patients and family caregivers.
Primary Outcome
Baseline: Patient adherence to a sodium-restricted diet was assessed using 24-hour urinary sodium excretion at 3-time points at baseline, 4-months, and 12 months.
Interventions
- BEHAVIORAL usual care
- BEHAVIORAL Family SWaP intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 316 participants |
| Start Date | 2015-03-01 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT03560206 record still lists
NCT03560206 is an interventional study that assigns participants to a tested intervention. The registered 316 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 2 interventions - of which usual care is the first listed.
NCT03560206 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03560206 about?
NCT03560206 is a clinical study titled "Effects of Family Sodium Watcher Program on Outcomes in Heart Failure Patient-Family Caregiver Dyads". The Family Sodium Watcher program in this study is designed to improve adherence to a sodium restricted diet in patients with HF using strategies that educate both patients and family caregivers about sodium monitoring and that stress a gradual progressive adaptation to low sodium food for both pati...
What is the current status of trial NCT03560206?
This trial is currently completed. It is a NA study. The enrollment target is 316 participants. The study started on 2015-03-01. Estimated completion is 2020-07-31.
What interventions are being tested in trial NCT03560206?
The interventions under investigation include: usual care (BEHAVIORAL), Family SWaP intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03560206?
This trial is sponsored by Misook L. Chung, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03560206's enrollment target sits among peer trials
316 321st of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04256317 · 316 participants · Phase 2
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- NCT04787042 · 316 participants · Phase 1
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
- NCT04802759 · 316 participants · Phase 1
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
- NCT05464056 · 316 participants · NA
BUILT Family Lifestyle Program for Children with ADHD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI